Expert Care for Advanced Lung Disease
Baylor Annette C. and Harold C. Simmons Transplant Institute at Baylor University Medical Center, part of Baylor Scott & White Health is one of the largest, most comprehensive multi-specialty transplant centers in the United States. Our lung transplant program offers sophisticated diagnostic testing and innovative therapies for patients with advanced chronic lung disease.
Since performing our first lung transplant in Texas in 1990, our team continues to be a leading force in lung disease treatment and outcomes. Baylor Dallas is not only home to one of the busiest adult extra corporeal membrane oxygenation (ECMO) programs in North Texas, but also home to the region's only ECMO deployment program.
Baylor Dallas is the top-ranked hospital in North Texas in pulmonology and continues to be ranked as one of America's top hospitals by
U.S. News & World Report. We accept chronic lung disease patients with complex conditions that other centers may deny. In addition, we are actively involved in research to improve outcomes after lung transplantation.
For more information on the Baylor Dallas Lung Transplant Program, call 214.820.6856 or explore the information below.
Lung Transplant Process
After your doctor refers you to Baylor Dallas for lung disease treatment, you'll undergo a series of tests and counseling to determine if you are a candidate for a lung transplant. The Lung Transplant Selection Committee will review the results to evaluate if you meet the lung transplant requirements. If so, you will be approved and placed on the list for transplant. Once on the waiting list, you'll be assigned a standard
Lung Allocation Score (LAS). Lungs are allocated to recipients according to the lung allocation score, blood type and geographic matching between donor and recipient.
Lung Transplant Requirements and Criteria
Our transplant team evaluates patients on a case-by-case basis and focuses on a patient's physiologic age (functional age) and overall health for determination of candidacy. Advanced age (over 65 years old) is a risk for shorter survival after lung transplantation—primarily as a consequence of other illnesses. Ordinarily, patients older than 65 are considered for lung transplantation if, with the exception of lung disease, they are otherwise healthy.
Diagnosis for Lung Transplant
There are a number of serious lung conditions, in which single or double lung transplant may be the best course of treatment.
Life After Lung Transplant Surgery
Patients who have undergone lung transplantation report a dramatic improvement in their quality of life. Following recovery from lung surgery, patients no longer require supplemental oxygen and are able to return to an active lifestyle with considerably more independence with their daily lives. On average, full recovery and physical rehabilitation following lung transplantation surgery takes 2-3 months.
In many ways, recipients become dedicated to caring for their new lungs after a lung transplant. There are many new medications that patients must begin taking to prevent rejection and infections; additionally there are lifestyle changes that patients must adhere to in order to avoid communicable illnesses. Good long-term outcome is significantly impacted by recipient compliance with post-transplant care and vigilance with his or her overall state of health.
Our Team of Lung Transplant Specialists
We performed our first lung transplant in Texas in 1990 and have continued to grow our lung disease treatment expertise and experience. Our team is led by:
- Dr. Randall L. Rosenblatt, chief of pulmonary medicine, medical director of lung transplantation
- Dr. Kenneth Ausloos, medical director, interstitial lung disease and pulmonary hypertension
- Dr. Puneet Garcha, assistant medical director of lung transplantation and advanced lung disease
- Dr. Howard J. Huang, associate medical director of lung transplantation and director of lung transplant research
- Dr. David Mason, lung transplantation and thoracic surgeon at Baylor Scott & White Health
- Dr. Gary Schwartz, surgical director of major airway disorders